Full Text View
Tabular View
No Study Results Posted
Related Studies
Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy
This study has been completed.
Study NCT00041795   Information provided by NeoTherapeutics

First Received on July 16, 2002.   Last Updated on June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Peripheral Nervous System Diseases
Additional conditions recognized in this trial
Demyelinating Diseases
Nerve Compression Syndromes
Nervous System Diseases
Neurologic Manifestations
Neurotoxicity Syndromes
Polyneuropathies
More general conditions related to this trial
Neuromuscular Diseases
Poisoning
Signs and Symptoms
Substance-Related Disorders
Interventions listed in this trial
leteprinim potassium (Neotrofin)
Sponsors listed in this trial
NeoTherapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services